New publications highlight clinical benefits of avinger pad therapies

Redwood city, ca / accesswire / april 21, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced the publication of two clinical studies in peer-reviewed journals, further supporting the clinical benefits of its therapeutic devices. the studies were based on separate clinical case series conducted by physicians at the division of cardiovascular disease and endovascular medicine at the einstein medical center in philadelphia, pennsylvania.
AVGR Ratings Summary
AVGR Quant Ranking